期刊
EMBO JOURNAL
卷 30, 期 15, 页码 3052-3064出版社
WILEY
DOI: 10.1038/emboj.2011.221
关键词
rapamycin; ribosome biogenesis; RPD3 histone deacetylase; Sch9; Stb3
资金
- Novartis Foundation for Biology and Medicine
- Swiss National Science Foundation [PP00P3-110770/3100A0-108114]
- European Research Council [ERC-2007-StG 206173-TOR]
- NIH [GM63952]
- Wellcome Trust
- Royal Society
- Scottish Universities Life Sciences Alliance
- SystemsX.ch initiative
- EPFL
TORC1 is a conserved multisubunit kinase complex that regulates many aspects of eukaryotic growth including the biosynthesis of ribosomes. The TOR protein kinase resident in TORC1 is responsive to environmental cues and is potently inhibited by the natural product rapamycin. Recent characterization of the rapamycin-sensitive phosphoproteome in yeast has yielded insights into how TORC1 regulates growth. Here, we show that Sch9, an AGC family kinase and direct substrate of TORC1, promotes ribosome biogenesis (Ribi) and ribosomal protein (RP) gene expression via direct inhibitory phosphorylation of the transcriptional repressors Stb3, Dot6 and Tod6. Deletion of STB3, DOT6 and TOD6 partially bypasses the growth and cell size defects of an sch9 strain and reveals interdependent regulation of both Ribi and RP gene expression, and other aspects of Ribi. Dephosphorylation of Stb3, Dot6 and Tod6 enables recruitment of the RPD3L histone deacetylase complex to repress Ribi/RP gene promoters. Taken together with previous studies, these results suggest that Sch9 is a master regulator of ribosome biogenesis through the control of Ribi, RP, ribosomal RNA and tRNA gene transcription. The EMBO Journal (2011) 30, 3052-3064. doi:10.1038/emboj.2011.221; Published online 5 July 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据